Qing Cong

Qing Cong


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2024 in Talanta
Verified
Journal Article
Closed access
LZLingyan Zhong
Lingyan Zhong
JZJianxujie Zheng
Jianxujie Zheng
ZWZengyu Wang
Zengyu Wang
LLLing Lin
Ling Lin
QCQing Cong
Qing Cong
Liang QiaoLiang Qiao
Liang Qiao

10 March 2022 in Journal of Lower Genital Tract Disease
Verified
Journal Article
Open access
CCCan Cui
Can Cui
YXYaoxing Xiao
Yaoxing Xiao
ELE. Lin
E. Lin
LLLingxiao Luo
Lingxiao Luo
XSXiaoyi Sun
Xiaoyi Sun
QCQing Cong
Qing Cong
Objectives: Although carbon dioxide laser vaporization is frequently used for treating vaginal intraepithelial neoplasia (VaIN), the optimal depth of epithelial destruction with laser vaporization requires elucidation. We aimed to evaluate VaIN depth and better illustrate epithelial destruction during laser vaporization. Materials and Methods: We included 246 women diagnosed with VaIN (low-grade VaIN [VaIN 1], 123 women; high-grade VaIN [VaIN 2/3], 123 women) using colposcopy-directed biopsy at our hospital from January 1, 2019, to April 30, 2020. The thickness of the noninvolved epithelium, if available, was determined. All available data, including cytology and histological information, were recorded. The t test and Pearson χ2 test were used for statistical analysis. Statistical significance was set at p < .05. Results: The involved epithelial thicknesses in VaIN 2/3 and VaIN 1 were 0.41 ± 0.21 and 0.40 ± 0.19 mm, respectively, which were both greater than their noninvolved epithelial thickness values (0.17 ± 0.10 and 0.17 ± 0.08 mm, p < .01 and p < .01, respectively). In subgroup comparisons between the VaIN 2/3 and VaIN 1 groups, the involved epithelial thickness did not differ between premenopausal patients, postmenopausal women receiving estrogen, and postmenopausal women who did not receive estrogen (p > .05). In the VaIN 2/3 group, the lesion thickness in premenopausal was greater than that in postmenopausal women receiving estrogen (p = .016) and those who were not receiving estrogen (p = .017). Conclusions: The thickness of VaIN is generally less than 1 mm for women of all ages, except in rare cases of visible lesions with papillary hyperplasia.

3 October 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
JXJingjing Xiao
Jingjing Xiao
ZCZiren Chen
Ziren Chen
YXYinping Xiao
Yinping Xiao
LSLong Sui
Long Sui
CWChao Wang
Chao Wang
QCQing Cong
Qing Cong
Introduction: A large-sample study focusing on VIN lesions of a more precise thickness is needed to help guide clinical treatment. This study aimed to investigate the depth of vulvar intraepithelial neoplasia (VIN) and involved skin appendages to provide evidence for laser surgery.Methods: The study retrospectively enrolled and analyzed the clinical characteristics of VIN patients in the obstetrics and gynecology department of a university hospital between January 1, 2019 and December 30, 2021. The study further explored the thickness of epithelium and skin appendages of 285 women with low-grade VIN (VIN1) and 285 women with high-grade VIN (VIN2/3).Results: The study included 1,139 (80%) VIN1 and 335 (20%) VIN2/3 cases. The VIN1 and VIN2/3 groups showed a significant difference in human papillomavirus infection (P<0.01) but not in cytology (P = 0.499). Most (89.90%, 1,325) cases occurred in one area of the vulva, whereas 10.11% were multifocal. VIN commonly occurred on the posterior fourchette (76.85%), labia majora (11.61%), and labia minora (9.92%). The VIN2/3 group reported a significantly higher positive rate for concurrent cervical and vaginal intraepithelial neoplasia (160 of 285) than the VIN1 group (321 of 953) (P=0.000). The involved epithelial thicknesses in VIN2/3 and VIN1 were 0.69 ± 0.44 and 0.49 ± 0.23 mm, respectively, both of which were greater than the corresponding noninvolved epithelial thickness (0.31 ± 0.19 and 0.32 ± 0.10 mm, P<0.001 and P<0.001, respectively). In cases of appendage involvement, the VIN thickness was 1.98 ± 0.64 mm.Conclusions: VIN thickness was generally ≤1 mm for the superficial lesions in non-hairy areas. However, for lesions extending onto hairy areas, the thickness was approximately 3 mm, leading to the destruction of involved skin appendages.

13 December 2025 in International Journal of Gynecological Cancer
Verified
Journal Article
Open access
ZCZiren Chen
Ziren Chen
YZYihui Zeng
Yihui Zeng
LLLingxiao Luo
Lingxiao Luo
JLJuan Li
Juan Li
LZLiangkai Zheng
Liangkai Zheng
QCQing Cong
Qing Cong
Cervical cancer remains a leading cause of gynecologic cancer-related mortality worldwide, with human papillomavirus (HPV) testing being a key screening tool. However, current guidelines often categorize high-risk HPV types broadly, overlooking their varying oncogenic potentials. This study aimed to develop and validate a machine learning model to predict cervical intra-epithelial neoplasia grade (CIN) 2 or worse (CIN2+) using HPV genotyping, cytology results, and patient age. A retrospective analysis was conducted using data from 52,063 patients (61,022 clinical records) from the Obstetrics and Gynecology Hospital of Fudan University, Shanghai, collected between October 2017 and June 2023. Clinical data included HPV genotyping, cytology results, and histopathologic diagnoses. Six machine learning algorithms (logistic regression, decision tree, random forest, Support Vector Machine-Radial Basis Function, XGBoost, and CatBoost) were compared, with performance evaluated using area under the curve, accuracy, sensitivity, and F1 score. The optimal model was validated using a temporal cohort from Obstetrics and Gynecology Hospital of Fudan University and external cohorts from Xiamen Maternal and Child Health Hospital and Jinan Maternal and Child Health Hospital. Among the models, CatBoost achieved the highest area under the curve (0.917) in internal validation, with an accuracy of 86% and sensitivity of 78% for CIN2+. External validation confirmed robust performance: 89% accuracy (Obstetrics and Gynecology Hospital of Fudan University), and 78% (Xiamen Maternal and Child Health Hospital), and 80% (Jinan Maternal and Child Health Hospital). Simulation analysis indicated that the AI (Artificial Intelligence)-guided strategy could reduce colposcopy referrals by 14.3%, whereas maintaining 96.8% sensitivity and an exceptional negative predictive value of 99.18%. A user-friendly tool (www.cervixcare.cn) was developed to provide individualized CIN2+ risk scores based on input variables. This multi-center-validated model enables precise risk stratification by accounting for HPV genotype-specific pathogenicity, improving clinical decision-making for cervical cancer screening and management.

5 July 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
CCCan Cui
Can Cui
ZCZiren Chen
Ziren Chen
LLLingxiao Luo
Lingxiao Luo
JZJianping Zeng
Jianping Zeng
XSXiaoyi Sun
Xiaoyi Sun
QCQing Cong
Qing Cong
Background: Loop electrosurgical excision procedure (LEEP) conization and hysterectomy are performed for some patients with papillary squamous cell carcinoma (PSCC), whereas only hysterectomy is performed for others. We aimed to determine the optimal management for PSCC.Methods: Patients diagnosed with PSCC by colposcopy-directed biopsy between June 2008 and January 2020 who underwent LEEP conization and hysterectomy or only hysterectomy at our hospital were enrolled. Results of cervical cytology, high-risk human papillomavirus testing, transvaginal sonography, pelvic magnetic resonance imaging, LEEP, hysterectomy, and pathology testing of colposcopy-directed biopsy samples were analyzed.Results: A total of 379 women were diagnosed with PSCC by colposcopy-directed biopsy; 174 underwent LEEP before hysterectomy and 205 underwent only hysterectomy. Patients underwent and did not undergo LEEP were aged 47 ± 11 years and 52 ± 11 years, respectively. Among women who underwent LEEP, the agreement between LEEP and hysterectomy pathology was 85.1%. For women who underwent only hysterectomy, the agreement between preoperative clinical staging and pathological staging after hysterectomy was 82.4%. For patients with preoperative imaging indicative of malignancy, the accuracy of LEEP for diagnosing and staging PSCC was 88.5%, whereas for the hysterectomy-only group, it was 86.2%. For patients without malignancy detected with imaging, the accuracy of LEEP for diagnosing and staging PSCC was 81.6%; however, for those who did not undergo LEEP, it was 70.0%.Conclusion: For women diagnosed with PSCC by colposcopy-directed biopsy, LEEP conization is necessary for an accurate diagnosis when imaging does not indicate cancer; however, LEEP is not necessary when imaging indicates cancer.

4 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
YHYundi Hu
Yundi Hu
HWHui Wang
Hui Wang
LQLing Qiu
Ling Qiu
XSXiaomei Sun
Xiaomei Sun
XWXin Wu
Xin Wu
Background/Objectives: Gastric-type endocervical adenocarcinoma (G-EAC) is a rare, aggressive, and HPV-independent subtype of cervical cancer with a poor prognosis. Due to its rarity, existing literature is often limited by small sample sizes, which hinders the development of evidence-based clinical management strategies. This study aims to evaluate the clinicopathological features, prognostic factors, and responses to postoperative adjuvant therapy in a large cohort of G-EAC patients compared with those with usual endocervical adenocarcinoma (UEA). Methods: We conducted a nested case–control study within a prospectively maintained surgical cohort at a national referral center in China. The study population included 195 pathologically confirmed G-EAC cases and 765 UEA cases. Patients were followed longitudinally with comprehensive clinical and survival data collection. One-to-one propensity score matching (PSM) was performed to balance demographic, clinical, and treatment variables between the groups. Survival outcomes were compared using Kaplan–Meier analysis, and independent prognostic factors were identified via Cox regression. Results: G-EAC patients demonstrated significantly worse survival outcomes than matched UEA patients, with 3-year progression-free survival (PFS) of 66.1% vs. 79.8% (p = 0.014) and 3-year overall survival (OS) of 74.9% vs. 84.6% (p = 0.033). Parametrial involvement and pelvic lymph node metastasis were identified as independent risk factors for both recurrence and death (p < 0.05). Regarding adjuvant treatment, combined radiotherapy and chemotherapy significantly improved survival compared with single-modality treatments (PFS: 65.2% vs. 43.6%; OS: 74.3% vs. 54.5%; p < 0.05); however, G-EAC remained less responsive to these therapies than UEA. Conclusions: G-EAC exhibits more aggressive clinical behavior and poorer survival outcomes compared to UEA. While combined radiotherapy and chemotherapy offer survival benefits, outcomes remain suboptimal. These findings underscore the urgent need for early detection strategies and the development of more effective targeted therapies for this specific subtype.